NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Boston Scientific Corporation (NYSE: BSX)

BSX Technical Analysis
As on 26th Nov 2021 BSX Share Price closed @ 38.57 and we RECOMMEND Sell for LONG-TERM with Stoploss of 39.74 & Buy for SHORT-TERM with Stoploss of 36.15 we also expect STOCK to react on Following IMPORTANT LEVELS.

BSX Share Price

Open 40.00 Change Price %
High 40.16 1 Day -2.13 -5.23
Low 38.44 1 Week -2.85 -6.88
Close 38.57 1 Month -4.68 -10.82
Volume 7614514 1 Year 0.09 0.23
52 Week High 45.88 | 52 Week Low 33.15
NYSE USA Most Active Stocks
DDR 15.44 -4.46%
BACA-U 302.00 0.67%
CCL 17.95 -10.96%
PFE 54.00 6.11%
BAC 45.76 -3.93%
RPAI 13.15 -3.17%
F 19.75 -2.47%
RLX 5.51 1.85%
NCLH 20.06 -11.36%
DAL 36.38 -8.34%
NYSE USA Top Gainers Stocks
EBR-B 5.77 454.81%
CARS 16.12 21.11%
CARS 16.12 21.11%
CARS 16.12 21.11%
STEM-WT 14.40 17.74%
CZZ 0.17 13.33%
CZZ 0.17 13.33%
BKSY-WS 1.30 9.24%
CNF 4.95 8.55%
CNF 4.95 8.55%
NYSE USA Top Losers Stocks
KWAC-WS 0.61 -93.97%
NSH-WS 14.00 -92.00%
NSH 14.00 -92.00%
NSH 14.00 -92.00%
NSH 14.00 -92.00%
NSH-U 14.00 -92.00%
MTEST 20.00 -20.16%
OIBR-C 0.72 -20.00%
FRX-WS 0.04 -20.00%
FRX-U 0.04 -20.00%
Daily Charts
Intraday Charts
Whats New @
Free Analysis
BSX Important Levels Intraday
BSX Target for Month November
4th UP TARGET49.71
3rd UP TARGET46.14
2nd UP TARGET43.93
1st UP TARGET41.72
1st DOWN TARGET35.42
2nd DOWN TARGET33.21
4th DOWN TARGET27.43
BSX Weekly Target
4th UP TARGET46.99
3rd UP TARGET44.29
2nd UP TARGET42.62
1st UP TARGET40.95
1st DOWN TARGET36.19
2nd DOWN TARGET34.52
3rd DOWN TARGET32.85
4th DOWN TARGET30.15
BSX Target for Year 2021
4th UP TARGET64.2
3rd UP TARGET55.98
2nd UP TARGET50.9
1st UP TARGET45.82
1st DOWN TARGET31.32
2nd DOWN TARGET26.24
3rd DOWN TARGET21.16
4th DOWN TARGET12.94
BSX Other Details
Segment EQ
Market Capital 61396410368.00
Sector Healthcare
Industry Medical Devices
Offical website >
BSX Address
BSX Latest News
Your Comments and Response on Boston Scientific Corporation
BSX Business Profile
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts. Address: 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234
© 2005-2021 All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service